Tretinoin Cream
FDA Recall NDC 51672-1394

Latest: Class III · Status: Ongoing · Initiated Sep 25, 2026 · 2 enforcement reports

Active & Historical Enforcement Reports

The FDA has identified 2 recorded enforcement report(s) associated with Tretinoin (NDC 51672-1394). A significant event, classified as Class III, was initiated on Sep 25, 2026 by Sun Pharmaceutical Industries, Inc.. The reported reason for this action was: "Failed Impurities/Degradation Specifications"

This recall is currently ONGOING. Healthcare providers and patients are advised to check their inventory immediately against the affected codes provided below.

Reported Recall Events

September 2026 Class III Recall: Failed Impurities/Degradation Specifications

Recall Number
Class III Ongoing
Reason for Recall
Failed Impurities/Degradation Specifications
Initiated
Sep 25, 2026
Reported
Oct 14, 2026
Quantity
N/A

Recall Profile & Regulatory Data

Event ID
99977
Classification
Class III
Enforcement Status
Ongoing
Recalling Firm
SUN PHARMACEUTICAL INDUSTRIES INC
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
US Nationwide.
Product Description
Tretinoin Cream UPS, 0.05%, 20g, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals USA Inc., Hawthorne, NY 10532, NDC 51672-1394-0.
Batch or Lot Expiration Information
Lot# AD96196, Exp Date: 12/31/2026.
Affected Packages Involved in this Recall
51672-1394-0Tretinoin
51672-1394-9Tretinoin

September 2026 Class III Recall: Failed Impurities/Degradation Specifications

Recall Number
Class III Ongoing
Reason for Recall
Failed Impurities/Degradation Specifications
Initiated
Sep 25, 2026
Reported
Oct 14, 2026
Quantity
N/A

Recall Profile & Regulatory Data

Event ID
99977
Classification
Class III
Enforcement Status
Ongoing
Recalling Firm
SUN PHARMACEUTICAL INDUSTRIES INC
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
US Nationwide.
Product Description
Tretinoin Cream USP, 0.05%, 45g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals USA Inc., Hawthorne, NY 10532, NDC 51672-1394-9.
Batch or Lot Expiration Information
Lot# AD96184, Exp Date: 12/31/2026.
Affected Packages Involved in this Recall
51672-1394-0Tretinoin
51672-1394-9Tretinoin

About FDA Recall Enforcement Reports

FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.

If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.